Inventor(s)

    Abstract

    Considerations related to crystalline form of Zavegepant intermediate i.e Methyl (R)-3-(7-methyl-1H-indazol-5-yl)-2-(4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxamido) propanoate

    Creative Commons License

    Creative Commons License
    This work is licensed under a Creative Commons Attribution 4.0 License.

    Share

    COinS